Analyst picks & changes

Centocor Inc.

(CNTO)

Business: Biopharmaceuticals

Morgan Stanley analyst Eric Hecht maintained his "buy" on the Malvern, Penn., company's shares following second quarter results below the Street consensus estimate of a loss of 13 cents.